SCOTTSDALE, Ariz., May 17, 2007 (PRIME NEWSWIRE) -- TASER International, Inc. (Nasdaq:TASR), a market leader in advanced electronic control devices, announced that a study by Cleveland Clinic reported that a standard electrical discharge from a TASER(r) X26 electronic control device (ECD) does not induce ventricular fibrillation.
